ACRIVON THERAPEUTICS INC. - COMMON STOCK
8.1400
09-5月-24 15:59:55
15 分の遅延
株式
-0.0900
-1.09%
本日の幅
8.0043 - 8.7400
ISIN
N/A
ソース
NASDAQ
-
24 4 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
10 4 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Acrivon Therapeutics Announces $130 Million Private Placement Financing
09 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
28 3 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
04 3 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
27 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
08 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Acrivon Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
06 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 1 2024 16:00:24 提供 Nasdaq GlobeNewswire
-
Acrivon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 1 2024 08:00:01 提供 Nasdaq GlobeNewswire
-
Acrivon Therapeutics Appoints Jean-Marie Cuillerot, M.D., as Chief Medical Officer
03 1 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Acrivon Therapeutics to Present at the Piper Sandler Annual Healthcare Conference
21 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Acrivon Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
09 11 2023 08:01:00 提供 Nasdaq GlobeNewswire
-
Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28 9 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
19 9 2023 16:32:13 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >